Trial Profile
Phase 4 Open-labeled Study to Compare the Anti-depressive Efficacy Between Mirtazapine and Psychotherapy for Patients With Interferon-related Depression During Antiviral Therapy for Hepatitis C.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2018
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary)
- Indications Depression
- Focus Therapeutic Use
- 27 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2018.
- 27 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 18 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.